A Study of SGB-9768 in Adult Healthy Volunteers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

May 3, 2025

Study Completion Date

October 17, 2025

Conditions

Healthy Volunteer

Interventions

DRUG

SGB-9768

SGB-9768 for sc injection

OTHER

Placebo

sterile normal saline (0.9% NaCl) for sc injection

Trial Locations (1)

Huashan hospital, Shanghai

All Listed Sponsors

lead

Suzhou Sanegene Bio Inc.

INDUSTRY

NCT06501573 - A Study of SGB-9768 in Adult Healthy Volunteers | Biotech Hunter | Biotech Hunter